Speclipse
PrivateLast Round
Private Equity
Jul 1, 2024
Total Funding Raised
$39.1M
Company Overview
Speclipse operates in Healthcare & Life Sciences and is based in Seongnam-si. Its latest recorded funding round was a Private Equity round in July 2024.
Speclipse is a medical technology company that develops AI-powered laser spectroscopy systems for skin cancer diagnosis and aesthetic medical applications.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Speclipse Comparables
Compare Speclipse with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DermaSensor, Inc. | 86% | |
| Vita Imaging Inc. | 84% | |
| Scibase Holding | 80% |
For institutional investors. Book with your work email.
Speclipse Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Jul 1, 2024 | ||||
| Series A | Aug 19, 2021 | ||||
| Corporate Funding | Nov 5, 2019 | ||||
| Seed | Nov 1, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Speclipse Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| InterVest | Seed |
| Lindeman Asia Investment | Corporate Funding |
| BNH INVESTMENT | Series A |
| K2 Investment Partners | Private Equity |
| SBVA | Seed |
| JB Investment | Seed |
| Signite Partners | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 1, 2016
$2.6M raised from InterVest, JB Investment, and SBVA.
For institutional investors. Book with your work email.
Speclipse Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Speclipse's valuation, stock price, and market status.
Is Speclipse a public or private company?
Speclipse is a private company.
What is the current stock price of Speclipse?
Speclipse is a private company, so its shares have no public market price. Caplight tracks Speclipse's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Speclipse worth (valuation)?
Valuation information for Speclipse is not publicly available.
Can I buy Speclipse stock?
Speclipse shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Speclipse's last funding round?
Speclipse's most recent funding round was Private Equity on July 1, 2024.
Who are the main investors in Speclipse?
Key investors in Speclipse include Signite Partners.
Will Speclipse IPO soon?
No public IPO plans have been announced for Speclipse.
How can I track Speclipse secondary market activity?
Caplight tracks bids, offers, and trades in Speclipse's shares on secondary markets.